Considerations for developing an immunization strategy with enterovirus 71 vaccine
about
Is a multivalent hand, foot, and mouth disease vaccine feasible?EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseasesHand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57.Risk Factors for Enterovirus A71 Seropositivity in Rural Indigenous Populations in West Malaysia.Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.Characterization of Coxsackievirus A6- and Enterovirus 71-Associated Hand Foot and Mouth Disease in Beijing, China, from 2013 to 2015.Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trialGenome analysis of enterovirus 71 strains differing in mouse pathogenicity.Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.
P2860
Q27010349-EEDA42F4-E707-4B50-8798-64C54467B9D0Q28076658-2A6A8805-6A83-4BB9-BF6A-66A2CC9E2377Q30249022-B934ACFA-CC22-4665-9F7B-4B99C0E4058AQ35915460-09158EFB-515B-4EEF-B763-B5BC916A11D8Q35920802-6F71D524-F97C-43D1-BC91-7133338E4CE1Q36479953-DDEC168E-E561-429B-B2F4-E6A82F6EA579Q36740549-E9F8ACD6-7906-4A66-BC7D-F3CCB7222F87Q37130763-B6DE225A-5417-4FEC-9002-5AB10136F4ECQ38802106-59AFE731-25B2-4AFA-9347-49FE80556A2BQ38840182-514CA75F-8B01-4D90-A92F-D090571EC378
P2860
Considerations for developing an immunization strategy with enterovirus 71 vaccine
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@ast
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@en
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@nl
type
label
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@ast
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@en
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@nl
prefLabel
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@ast
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@en
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@nl
P3181
P1433
P1476
Considerations for developing an immunization strategy with enterovirus 71 vaccine
@en
P2093
Hongzhang Yin
Zijian Feng
P304
P3181
P356
10.1016/J.VACCINE.2014.10.081
P407
P577
2014-11-08T00:00:00Z